News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Marc Eid: Come check Poster Board 224 by Talal El Zarif and Karl Semaan at ASCO24
Photo taken from Marc Eid/X
Jun 4, 2024, 09:20

Marc Eid: Come check Poster Board 224 by Talal El Zarif and Karl Semaan at ASCO24

Marc Eid, Postdoctoral research fellow in Medical Oncology at the Dana-Farber Cancer Institute, shared on X:

“Come check Poster Board 224.

Talal El Zarif and Karl Semaan put together a large dataset from 29 institutions to answer a timely and important question in RCC.”

Source: Marc Eid/X

ASCO ASCO24 cancer Dana-Farber Cancer Institute Karl Semaan Marc Eid OncoDaily Oncology RCC Talal El Zarif
Special Coverage
Blog
Apr 1, 2025, 17:49
Last post of the Trailblazers in Breast Cancer Research series - BCRF
Blog
Apr 1, 2025, 17:42
Sophia Hemsey: I had pleasure of partnering with St. Baldrick's Foundation for Alpha Kappa Psi's 5th annual Cocky and Bald event
Blog
Apr 1, 2025, 17:28
Ester Demirtshyan: Consider donating $10 to City of Smile to help children fighting cancer in Armenia
Blog
Apr 1, 2025, 17:18
Exploring AI’s Role in Cancer Care at ESTRO 2025
Blog
Apr 1, 2025, 17:01
The Power Over Cancer Gathering at Springhill Church - UF Health Cancer Center
Blog
Apr 1, 2025, 16:40
Estelamari Rodriguez: Speaking at the Latino Medical Student Association regional conference
Blog
Apr 1, 2025, 16:32
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers
Blog
Apr 1, 2025, 16:21
Azra Raza featured in SPCC's fifth episode of the "Behind Every Drug There’s a Story" series
Blog
Apr 1, 2025, 16:18
The EBMT 2025 Election Results
Career
Apr 1, 2025, 16:02
Jay Bhattacharya begins his tenure as the 18th NIH Director - National Institutes of Health
Positive
Apr 1, 2025, 15:45
Mark Lanasa: Positive CHMP opinion for BeOne Medicines' first-line immunotherapy in ES-SCLC
Blog
Apr 1, 2025, 15:09
Hagop Kantarjian: Success, optimism, and challenges on the therapeutic horizon of acute myeloid leukemia